Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Surveillance of Takecab Tablets "Supplement to Helicobacter Pylori Eradication"

NCT03219723 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03219723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03219723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Surveillance of Takecab Tablets "Supplement to Helicobacter Pylori Eradication"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
September 1, 2015
Completion date
April 30, 2017
Enrollment
560 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric/duodenal ulcer, gastric malt lymphoma, idiopathic thrombocytopenic purpura, or h. pylori gastritis, and other